Adrien Bigot

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

Sophie Georgin‐Lavialle, Benjamin Terrier, Alexis F. Guédon et al. · British Journal of Dermatology · 2021 · 417 citations · Full text

Medicine, Hematology, Pathology +16

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

Maël Heiblig, Marcela A. Ferrada, Matthew T. Koster et al. · Blood · 2022 · 207 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

The Clinical Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis: Data From a French Nationwide Study of Fifty‐Seven Patients

M. Jachiet, B. Flageul, Alban Deroux et al. · Arthritis & Rheumatology · 2014 · 178 citations

Medicine, Immunology, Dermatopathology +13

Glial Fibrillary Acidic Protein Autoimmunity

Alice Gravier-Dumonceau, Roxana Améli, Véronique Rogemond et al. · Neurology · 2021 · 149 citations · Full text

Life Sciences, Neurology, Neuroscience +17